Recent studies (1) have concluded that remote health monitoring (RHM) has the potential to systematically reduce the growing cost burden of chronic diseases such as diabetes.

The costs of chronic diseases constitute approximately two-thirds of total healthcare costs today, in the OECD and BRIC (Brazil, Russia, India, and China) countries (2).

It is important to underline that in European countries medical costs for Type 1 Diabetes Mellitus (T1DM) have been increasing over the past few years for about 7-10% of total health expenditure, and hospitalisation and chronic complications of T1DM cost more than specialist care or pharmaceutical expenditure.

Particularly, the direct costs of T1DM without complications amount to about 800 €/year per person, while, in the presence of complications it varies between 3,000 and 36,000 €/year per person (3).

T1DM is therefore a major candidate for the application of mHealth apps, since an innovative and holistic approach to management and self-management of T1DM can significantly improve treatment outcomes, and overall patient disease knowledge, while reducing healthcare costs.

(1) Thokala P, Kruger J, Brennan A, Basarir H,Duenas A, Pandor A, Gillett M, Elliott J, Heller S., Assessing the cost-effectiveness of Type 1 diabetes interventions: the Sheffield Type 1 Diabetes Policy Model, Diabet Med. 2014 Apr;31(4):477-86

(2) McKinsey & Company, mHealth: A new vision for healthcare, 2012